79 reports of this reaction
23.0% of all NICKEL reports
#1 most reported adverse reaction
DRUG HYPERSENSITIVITY is the #1 most commonly reported adverse reaction for NICKEL, manufactured by Boiron. There are 79 FDA adverse event reports linking NICKEL to DRUG HYPERSENSITIVITY. This represents approximately 23.0% of all 344 adverse event reports for this drug.
Patients taking NICKEL who experience drug hypersensitivity should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG HYPERSENSITIVITY is a frequently reported adverse event for NICKEL, accounting for a significant proportion of all reports.
In addition to drug hypersensitivity, the following adverse reactions have been reported for NICKEL:
The following drugs have also been linked to drug hypersensitivity in FDA adverse event reports:
DRUG HYPERSENSITIVITY has been reported as an adverse event in 79 FDA reports for NICKEL. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG HYPERSENSITIVITY accounts for approximately 23.0% of all adverse event reports for NICKEL, making it one of the most commonly reported side effect.
If you experience drug hypersensitivity while taking NICKEL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.